Literature DB >> 8165823

Fenoterol metabolism in man: sulphation versus glucuronidation.

R Hildebrandt1, B Wagner, K Preiss-Nowzohour, U Gundert-Remy.   

Abstract

1. Plasma levels of fenoterol (F) and its conjugate metabolites were determined in healthy female subjects and in pregnant women treated for preterm labour. Sulphate (S) and glucuronide (G) conjugates could be quantified. 2. In the healthy volunteers, AUC of both the metabolites was half that of parent compound (AUC-S/AUC-F: 0.42; 0.14-1.16) (AUC-G/AUC-F: 0.49; 0.18-0.86) during i.v. administration of the drug and was several fold that of parent drug (AUC-S/AUC-F: 116.9; 36.4-353.3, AUC-G/AUC-F: 19.9; 5.1-57.5) after p.o. administration indicating extensive presystemic elimination. 3. In the healthy subjects, the AUC ratio of G:S was 1.1 (0.5-2.6) and 0.16 (0.10-0.27) after i.v. and p.o. administration, respectively, thus indicating that sulphation is the prevailing metabolic pathway in the presystemic elimination. 4. In patients, concentration ratios were used for the analysis. During continuous i.v. treatment, Css-S/Css-F was 3.8 (2.5-4.8) and Css-G/Css-F was 1.5 (0.7-2.1). During p.o. treatment Csstrough S/Csstrough-F was 69.4 (32.1-145.7) and Csstrough-G/Csstrough-F 9.4 (5.6-13.2).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165823     DOI: 10.3109/00498259409043222

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  5 in total

1.  The stereoselective sulfate conjugation of 4'-methoxyfenoterol stereoisomers by sulfotransferase enzymes.

Authors:  Lalitha V Iyer; Anuradha Ramamoorthy; Ewelina Rutkowska; Anna M Furimsky; Liang Tang; Paul Catz; Carol E Green; Krzysztof Jozwiak; Irving W Wainer
Journal:  Chirality       Date:  2012-06-29       Impact factor: 2.437

2.  Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3.

Authors:  Haruka Nishimuta; Masayuki Tsujimoto; Kenichiro Ogura; Akira Hiratsuka; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

Review 3.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

4.  Development and validation of a sensitive LC-MS/MS method for the determination of fenoterol in human plasma and urine samples.

Authors:  M Sanghvi; A Ramamoorthy; J Strait; I W Wainer; R Moaddel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-06-26       Impact factor: 3.205

5.  Pharmacokinetics and metabolism of (R,R)-methoxyfenoterol in rat.

Authors:  D Siluk; D E Mager; H S Kim; Y Wang; A M Furimsky; A Ta; L V Iyer; C E Green; I W Wainer
Journal:  Xenobiotica       Date:  2010-03       Impact factor: 1.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.